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Abstract
AIM: Candida esophagitis is a frequent infection in
immunocompromised patients. This study was designed to
determine its characteristics in non- human immune deficiency
virus (HIV) infected patients attending a teaching hospital.
METHODS: Clinical records of all patients coded by
international classification of diseases 9th revision with
clinical modifications’ (ICD-9-CM), with candida esophagitis
diagnosed by esophagogastroduodenoscopy (EGD) and
histopathology over a period of 5 years were studied.
RESULTS: Fifty-one patients (27 males, 24 females, range
21-77 years old and mean age 52.9 years) fulfilled the criteria
(0.34 % of the EGD). The common predisposing factors
were carcinoma (OR 3.87, CI 1.00-14.99) and diabetes
mellitus (OR 4.39, CI 1.34-14.42). The frequent clinical
symptoms were retrosternal discomfort, dysphagia and
epigastric abdominal pain with endoscopic appearance of
scattered mucosal plaques. Another endoscopic lesion was
associated with candida esophagitis in 15 % patients.
CONCLUSION: Carcinomas, diabetes mellitus, corticosteroid
and antibiotic therapy are major risk factors for candida
esophagitis in Pakistan. It is an easily managed complication
that responds to treatment with nystatin.
Yakoob J, Jafri W, Abid S, Jafri N, Islam M, Hamid S, Shah HA,
Hussainy AS. Candida esophagitis: Risk factors in non-HIV




Infective esophagitis is a rare disease, affecting mostly
immunocompromised patients. Candida esophagitis is one of
the most common opportunistic infections in patients with
impaired immunity and the most common cause of esophageal
disease in patients with acquired immune deficiency syndrome
(AIDS)[1]. It also occurs in debilitated patients who have received
broad-spectrum antibiotics, steroids and immunosuppressants.
With the advent of transplantation and AIDS, esophageal
infection is now a common medical problem[2]. The common
infections involving immunocompromised non-human
immunodeficiency virus (HIV) infected patients include
candida and viral diseases such as cytomegalovirus (CMV)
and herpes simplex virus (HSV)[2]. Immunocompromised
patients who develop esophageal symptoms need to undergo
endoscopy to rule out candida esophagitis. It is well
recognized that candida esophagitis may coexist with other
esophageal disorders in these patients[3]. The occurrence of
multiple simultaneous processes makes definitive endoscopic
examination important[4]. Several studies have been carried
out in the west for candida esophagitis but it has not been
studied before in Pakistan. Incidence of AIDS and HIV
prevalence are still very low in Pakistan[5]. The purpose of our
study was to assess the risk factors associated with candida




The study was conducted at Agha Khan University Hospital
(AKUH) in Karachi, a private Academic Medical Center that
offers state of the art medical facilities and is used as a referral
center for patients from all over the country for expert opinion
and treatment. Karachi is a southern port and the largest
metropolitan city in Pakistan with a population of over 11
million. In August 2002 we carried out a retrospective analysis
of medical records of all the patients who attended endoscopy
unit of gastrointestinal section at the AKUH from January
1997-December 2001 and were diagnosed as candida
esophagitis. These patients had undergone endoscopy for
symptoms arising from the upper gastrointestinal tract over
this period and were diagnosed on the basis of endoscopy and
histopathology as candida esophagitis. Clinical symptoms at
the time of presentation, diagnosis, drug treatment dosage and
duration preceding the symptoms such as nystatin suspension
or fluconazole, past history of oral candidiasis, candida
esophagitis, neutrophil and lymphocyte counts from complete
blood picture, random blood glucose, hepatitis B, C and HIV
serology were noted. A lymphocyte count was described as
low when it was less than 1.5×109 per liter[6]. All endoscopic
examinations were performed by staff-members of our
hospital’s gastroenterology section, using an Olympus
videoscope GIF x Q 140. Candida esophagitis was diagnosed
when characteristic candidal plaques were endoscopically
identified and pathological confirmation of yeast forms typical
for candida was found in association with an active esophagitis.
Case patients were labeled as group A and the control group
as group B which consisted of those patients without a diagnosis
of candida esophagitis and in whom an endoscopic examination
was performed immediately before and after every case patient
was examined endoscopically (2 controls per case). Therefore,
candida esophagitis cases and controls were evaluated by the
same medical team using the same diagnostic criteria.
Endoscopy
To describe the severity of candida esophagitis both in
AIDS[7,8] and in non-AIDS populations, a grading scale was
described by Kodsi et al[9] or a modification thereof has been
used[10]. Candida esophagitis was graded as the following:
Grade 1 as scattered mucosal plaques involving less than 50 %
of the esophageal mucosa, grade 2 as mucosal plaques involving
more than 50 % esophageal mucosa, grade 3 as confluent plaque
material circumferentially coating at least 50 % of the esophageal
mucosa but without luminal impingement, grade 4 as
circumferential plaque mat coating at least 50 % of the
esophageal mucosa with luminal impingement despite air
insufflations. In most cases, an ulcer could be readily distinguished
endoscopically by the marked hyperemia and granularity of
the ulcer base from the surrounding candida esophagitis.
Histopathology
At the time of endoscopy, routine biopsies were performed on
all endoscopic abnormalities. At least 2 biopsies were
performed on each esophageal lesion with standard biopsy
forceps. All tissue specimens were submitted for routine
histopathology, and stained with hematoxylin-eosin (H-E) and
periodic acid-Schiff stains (PAS). In the presence of ulcer
tissue, immuno-histochemical staining for CMV and HSV was
performed using previously described technique to confirm
infection[3]. An ulcer was considered secondary to candida
esophagitis alone when it was found endoscopically and
histopathologically. Fungal organisms compatible with
candida were seen in the superficial epithelium, there was an
absence of viral cytopathic effect histopathologically, no
clinical or endoscopic evidence of gastroesophageal reflex
disease or drug-induced esophagitis existed.
Statistical analysis
Results were expressed as mean ± standard deviation, median
range for all continuous variables (e.g., age) and number
(percentage) for categorical data (e.g., gender, diabetes
mellitus, steroids, etc) were provided. Univariate analysis was
performed using the independent sample t-test, Pearson Chi-
square test and Fisher exact test when ever appropriate. A P
value <0.05 was considered as statistically significant. All P
values were two sided. Statistical interpretation of data was




During the study period, 15 000 upper endoscopies were
performed in our endoscopy unit. Fifty-one patients were
diagnosed with candida esophagitis on the basis of endoscopic
and histopathologic criteria. The age, sex and percentage of
inpatients are given in Table 1.
Risk factors
The common risk factors for candida esophagitis were
carcinoma (OR 8.05, 95 % CI 1.91-47.1 and P=0.001),
uncontrolled diabetes mellitus (OR 7.34, 95 % CI 2.26-27.5
and P=0.001), corticosteroid therapy (OR 6.67, 95 % CI 2.20-
22.3 and P=0.001) and antibiotics (OR 4.56, 95 % CI 1.14-
21.5 and P=0.02) (Table 2).
Clinical feature
The clinical details are given in Table 1. The clinical symptoms
in group A were retrosternal discomfort in 39.2 % (20/51) patients,
of these 6/20 were associated with dysphagia and 3/20 with
epigastric pain. Dysphagia was present in 25.4 % (13/51) and
epigastric symptoms in 35.2 % (18/51) with only 9/18
describing it as an epigastric pain (Table 1). In control group
B, retrosternal discomfort was described in 30.3 % (31/102),
dysphagia in 19.6 % (20/102) and epigastric symptoms in 50
% (51/102). These patients responded well to treatment with
nystatin or fluconazole, 84.3 % (43/51) and 15.7 % (8/51),
respectively (Table 1).
Table 1  Details of patients presenting with candida esophagitis
and controls
Cases  Control
 n=51    n=102
Sex
    Male 27 (53)    58 (57)
    Female 24 (47)    44 (43)
Age in years (yrs)
    Range: 21-77     19-74
    Mean ±SD           52.9±14.6              50.08±12.64
No: % of In-patients 34 (64)    58 (54)
Risk factors for candida esophagitis
    Steroid therapy           15 (29.4 %)   6 (5.8 %)
    Diabetes mellitus type 1 and 2           14 (27.4 %)   5 (4.9 %)
    Carcinoma           10 (19.6 %)   3 (2.9 %)
    (e.g. breast, gastric, esophagus)
    Broad spectrum antibiotics             8 (15.6 %)   4 (3.9 %)
    Chronic liver disease             2 (3.9 %)   6 (5.8 %)
    Tuberculosis             2 (3.9 %)   1 (0.9 %)
    Ischemic heart disease - 26 (25.4 %)
    Peptic ulcer disease - 26 (25.4 %)
    Hypertension - 20 (19.6 %)
    Chronic anemia -   2 (1.9 %)
    Arthritis -   1 (0.9 %)
    Primary Infertility -   1 (0.9 %)
    Osteoporosis -   1 (0.9 %)
Clinical symptoms
    Retrosternal discomfort           20 (39.3 %) 31 (30.3 %)
    Dysphagia           13 (25.4 %) 20 (19.7 %)
    Epigastric symptoms           18 (35.3 %) 51 (50 %)
Endoscopic grading
    Grade 1   9
    Grade 2 19
    Grade 3 10
    Grade 4 13
Treatment
Nystatin         84.3 % (43/51)
Fluconazole         15.7 % (8/51)
Results were expressed as number and percentage, mean ±
standard deviation (SD).
Polymorphonuclear leucocyte and lymphocyte counts
All of our patients had polymorphonuclear leucocyte count
within the normal range, while 33.3 % (17/51) had lymphocyte
count below the normal range. These patients were mostly those
who were on steroid or antibiotics therapy (Table 3).
Endoscopy finding
The endoscopic appearance of plaques varied in color from
yellow to white. With increasing severity, scattered mucosal
plaques coalesced circumferentially coating the mucosal
surface and impinged into the esophageal lumen. In group A,
9 patients had localized disease, 5 patients had disease more
prominent in the distal esophagus than in proximal esophagus,
while it involved middle esophagus and middle to distal
esophagus equally in 4 patients (Table 1). Esophageal
ulceration was noted endoscopically and histopathologically
in 3.9 % (2/51). In these patients, ulcer was believed to be
secondary to candida esophagitis alone, as other etiologies of
esophageal ulceration were excluded by testing for CMV, HSV
and HIV by serology and immuno-histochemistry. In 15.6 %
(8/51) of group ‘A’ patients, associated endoscopic findings
included 7.8 % (4/51) with antral gastritis, 1.9 % (1/51) with
gastric ulcer, 5.8 % (3/51) with duodenitis. In control group B
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esophageal disease was found in 35.3 % (36/102) cases, gastric
disease in 38.3 % (39/102) cases, and duodenal pathology was
seen in 26.4 % (27/102) cases.
Correlation of clinical symptoms and endoscopic feature
There was no correlation between clinical symptoms and
endoscopic findings.
Hepatitis B, C and HIV serology
HIV serology was negative for hepatitis B, and 9.8 % (5/51)
were positive for hepatitis C virus.
Histopathology
Histopathology revealed varying degrees of hyperplastic
squamous mucosa with moderate-severe degree of acute-
chronic inflammation in the surface epithelium. Mucosal
surface was covered with desquamated epithelium and
inflammatory necrotic slough. Superficial colonies of candida
organism showed non-branching hyphae. In cases of ulcerative
esophagitis, intact and focally ulcerated mucosa revealed
moderate-severe inflammation, basal cell hyperplasia with
non-septate fungal hyphae.
Table 2  Results of univariate analysis of potential risk factors
for acquisition of candida esophagitis
Variable              No. of           No. of           Odd ratio      P value
           cases (%)    control (%)       (95% CI)
Carcinoma            10 (19.6 %)      3 (2.9 %)      8.05 (1.91-47.1)      0.001
Diabetes mellitus          14 (27.4 %)      5 (4.9 %)      7.34 (2.26-27.5)      0.001
Prior use of steroid        15 (29.4 %)      6 (5.8 %)      6.67 (2.20-22.3)      0.001
Prior use of              8 (15.6 %)      4 (3.9%)       4.55 (1.14-21.5)      0.02
antibiotics
Table 3  Distribution of low lymphocyte counts in patients
presenting with candida esophagitis





Chronic liver disease 1
DISCUSSION
Our study is the first attempt to evaluate the risk factors and
endoscopic manifestations of candida esophagitis in Pakistan,
an area where AIDS is not endemic. All of our patients
diagnosed with candida esophagitis did not have oral thrush.
This was similar to a study by Bonacini et al in which 110
HIV positive patients with esophageal symptoms, 38 % of those
without oral thrush had candida esophagitis[11]. In this study,
the patients had oral, intravenous and nebulizer steroid
treatment in varying durations and doses of therapy. Steroid
levels were not measured on admission. However, steroid
therapy was associated with lymphopenia and 33.3 % of our
patients presented with a low lymphocyte count[12]. Diabetic
patients complicated with candida esophagitis had uncontrolled
diabetes at the time of presentation, irrespective of its type.
Malignancies beside other mechanisms were also associated
with esophageal stasis due to mechanical obstruction that
predisposes to candida esophagitis[13]. However, esophageal
obstruction was not a feature in our cases of candida esophagitis
associated with malignancies. A high frequency of bacterial
or mycotic infections has been reported in HCV-associated
membranoproliferative glomerulonephritis and diabetes mellitus
due to acquired defects of polymorphonuclear leukocyte (PMN)
functions[14,15]. In HIV seropositive cases, coexistent candida
esophagitis and tuberculosis have been frequently described
[16], but in non-HIV immunosuppressed patients, there were
few reports of active pulmonary or intestinal tuberculosis
associated with candida esophagitis[17].
     Epigastric pain has been known to be associated with
candida infection[18]. In our study, no correlation was found
between the symptoms and the endoscopy grade score similar
to another study[19]. At endoscopy, the presence of classic
whitish exudates or plaques should predict candidiasis in at
least 90 % of cases, although viral infection occasionally might
cause a similar appearance[11]. We found that candida
esophagitis resulted in typical endoscopic appearances and both
characteristic and uniform histopathologic findings. These
candida esophagitis patients were treated with either nystatin
5 ml QDS/fluconazole 100 mg a day by mouth for 5 days.
None of these candida esophagitis patients was found to be
resistant to this treatment. As treatment with fluconazole was
expensive, fewer patients were prescribed this medication.
Culture for identifying candida species was not carried out, as
it would have added cost to the management of disease. The
limitation of our study included a small number of patients
and a retrospective design. There were few patients with risk
factors in the control group B as their stable disease did not
predispose them to candida esophagitis (Table 1).
     The implications of our study are that in Pakistan candida
esophagitis is associated with chronic diseases and those on
treatment with corticosteroids and antibiotics are predisposed
to it. Patients on these medications need to be monitored and
reviewed frequently. Candida esophagitis should be considered
early in patients who have been on steroids and antibiotic
treatment and presented with upper gastro-intestinal symptoms.
Oral candidiasis does not accompany candida esophagitis.
Our study showed that candida esophagitis by itself was an
easily managed complication. In conclusion, candida
esophagitis in Pakistan is more common due to chronic
diseases, corticosteroid and antibiotic therapy which impaires
the immune system rather than as an AIDS-defining disease.
It occurs in the absence of local obstructive lesions and
responds to treatment with nystatin and fluconazole.
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